The use of various types of filters in anaesthesia and intensive care seems ubiquitous, yet authentication of the practice is scarce and controversies abound. This review examines evidence for the practice of using filters with blood and blood product transfusion (standard blood filter, microfilter, leucocyte depletion filter), infusion of fluids, breathing systems, epidural catheters, and at less common sites such as with Entonox inhalation in non-intubated patients, forced air convection warmers, and air-conditioning systems. For most filters, the literature failed to support routine usage, despite this seemingly being popular and innocuous. The controversies, as well as guidelines if available, for each type of filter, are discussed. The review aims to rationalize the place of various filters in the anaesthesia and intensive care environment.
Despite blood and blood product transfusions being handled frequently by anaesthetists, anaesthesia texts seldom review the practice and controversies of filter use during transfusion therapy. Two relevant and increasingly well-known issues for modern medicine are the spread of infection by medical intervention, and effective cost utilization in hospitals. Anaesthesia and intensive care are not exempt from implementation of practices designed to achieve these goals. One of several methods proposed to limit the spread of infection is routine use of filters. Use of various types of filters in our speciality seems ubiquitous, yet authentication of the practice is scarce and controversies abound. In addition, our search did not reveal any comprehensive account of the various filters used in anaesthesia and intensive care. Thus, this review examines evidence related to the practice of using filters with blood and blood product transfusion, infusion of fluids, breathing systems, epidural catheters, and relatively less common sites of filter usage such as with Entonox (nitrous oxide/oxygen) inhalation in unintubated patients, forced air convection warmers, and airconditioning systems. Controversies, as well as guidelines if available, for each of these filters, are discussed. We hope to rationalize the place of various filters in anaesthesia and intensive care in the current environment. For data collection we conducted a Medline search, studied previous reviews of different types of filters [1] [2] [3] , their cross-references, and other articles gathered on the subject while reading relevant journals.
BLOOD FILTERS
Anaesthetists constitute one of the largest percentages of specialists dealing with blood and blood products. Consequently discussion about complications of blood transfusion is common and extensive. However, the use of blood filters has not been subject to the comprehensive review it merits in anaesthesia texts. The need to filter clots and other debris formed in stored blood was recognized at an early stage as a means of preventing embolization 4, 5 . Early removal techniques used combinations of wire screens and cotton gauze to filter larger clots 6 . Great advances have been made in the field of blood filtration, with three generations of filters now available ( Table 1) . The use of a first generation blood filter (Figure 1 ) appears indispensable and is well accepted. Our goal was to determine whether the less common practice of using a second generation blood filter for microfiltration or a third generation blood filter for leucocyte reduction of blood and blood products has a place in modern transfusion therapy.
SECOND GENERATION BLOOD FILTERS (MICROFILTERS)
The 1960s witnessed development of open-heart surgical techniques and improved methods of resuscitation of trauma victims, wherein massive blood transfusions are frequently used. Consequently, recommendations to use microfilters 7 of pore size 20-40 µm to remove microaggregates (MAs) from the transfusion 8 appeared. Initial enthusiasm for microfilters led to further investigation of the clinical importance of removing MAs [9] [10] [11] . This unfurled contrary views, but before considering microfilter use in current practice, the pathophysiology of MA formation and sequelae are discussed.
Microaggregates (MAs)
Within a few hours of blood collection, platelets 419 FILTERS IN aggregate in stored blood to form loosely bound structures that by 24 to 48 hours also trap degenerating white blood cells and fibrin precipitates 12 . These MAs, of 10-40 µm size, are formed in a timedependent process such that numbers are increasing significantly after five or more days of storage 13 . Though formation of MAs is independent of the nature of anticoagulant used, their rate of formation depends on the type of anticoagulant used, being most rapid in heparinized blood. Although citratephosphate-dextrose-adenine (CPDA) anticoagulated blood develops MAs faster than blood containing ACD in the first week, formation occurs irrespective of storage solution by two weeks, with eventually 50-250 million MAs present per unit. Blood stored in saline-adenine-glucose-mannitol (SAGM) solution is also not exempt from MA formation 14, 15 although the number formed is significantly less 16 than in CPDA blood.
Given the average size of MA debris, their transfusion is not prevented by a standard 170 µm filter. Screen or depth filters must be used to prevent infusion of MAs (Table 1 ). Owing to the disadvantages of depth type microfilters, screen microfilters are more commonly used.
Is Microaggregate Transfusion Harmful? Microaggregates and Nonhaemolytic Febrile Transfusion Reaction (NHFTR)
Febrile transfusion reaction is defined as a temperature rise of >1°C above baseline during transfusion of blood or leucocyte-containing blood components, that is without other explanation. These reactions are due to interaction between HLA Class I antigens present on transfused lymphocytes, granulocytes or platelets and mostly leucocytes 17 in donor units, and antibody in previously alloimmunized recipients. The incidence of NHFTRs varies from 0.5% 17 to 6.6% 18 but may be as high as 45% in chronically infused patients, such as those suffering from thalassaemia 18 . It is the commonest reaction, accounting for 70% of all transfusion-related problems 19 . Transfusion of expensive leucocyte-reduced red cell concentrates is one method of avoiding NHFTRs.
A simpler and less expensive method of preventing NHTRs is use of a microfilter to remove leucocytecontaining MAs. Different studies 16, 20, 21 confirm that microfilters reduce the rate of NHFTR by fivefold and if combined with centrifugation (which probably incorporates granulocytes into MAs) by 98%.
Microaggregates and Pulmonary Injury
A relationship between microembolic blockage of pre-capillary arterioles and acute respiratory distress syndrome (ARDS) is often proposed [22] [23] [24] . Stored platelet concentrate MAs have been shown to result in ultrastructural lesions similar to those observed in situations leading to pulmonary dysfunction 25 . Several authors 8, 15, 26, 27 suggest altered pulmonary function in the pulmonary circulation after only two to three units of transfused blood. Despite animal and human studies, the issue of MA related lung injury is contentious and the benefit of microfilters in decreasing lung dysfunction is not firmly established. The routine use of microfilters to decrease lung dysfunction is not supported 6, 7, 28 .
Other adverse effects of MA transfusion
Thrombocytopenia following blood transfusions can occur after less than a five unit transfusion 29 . The fall in platelet count is greatest at 72 hours after transfusion 29 and can be only partially be explained by the dilutional effect [29] [30] [31] . Lim et al 32 found that the fall in platelet count decreased tenfold if microfilters were used. This effect was studied using radiolabelled platelets by Bareford 29 who showed that splenic sequestration of platelets was less after a microfilter was included during transfusion.
Fibronectin is an opsonic circulating glycoprotein involved in coating invading organisms and debris and presenting them to reticulo-endothelial system (RES) for elimination from the circulation. It has been hypothesized that MAs probably adhere to fibronectin, leading to its premature removal from circulation by the RES 23, 29 and subsequent depletion. Blood transfusion through a standard filter results in a significant fall in fibronectin levels compared with transfusion through a microfilter 33 . In an in vitro study of stored blood collected via microfilters, a decrease in the number of basophils and thus in the histamine levels was noted 34 .
There is little information about the potential complications associated with MAS during transfusion, and there is no case report or scientific trial that identifies potential adverse effects as clinically relevant.
Exsanguination
The time used to prime filters and the resistance to blood flow through them are seen as impediments to efficiency when transfusing a bleeding, critically hypovolaemic patient 26 . However, the priming of a filter seldom takes more than one minute 36 . Also, resistance to flow through microfilters is not significantly different from that of standard filters until three to four units of whole blood have passed through a depth filter or seven or eight units of whole blood through a screen filter 36 . Czaika et al 40 reported that flow rates of packed red cells through a 170 µm standard blood filter were slower that through three different types of microfilters. An interesting finding by Linko 41 was that pre-warming blood to 37°C increased the blood flow through microfilters by 49 to 86%. As expected, screen filters gave higher flow rates than depth filters. Of clinical relevance was the fact that the size of the venous cannula and the transfusion set were a greater influence on flow resistance than the type of blood filter.
The weight of evidence suggests the problem of exsanguination in a critically hypovolaemic patient is overemphasized. Other factors affecting blood flow rate are more important determinants of rate of transfusion than the filters themselves.
Platelet retention
Loss of platelets occurs if fresh blood is transfused through microfilters 42 . Snyder et al 43 also showed that transfusing whole blood transfusion through a depth microfilter caused significant loss of donor platelets, although infusion of donor platelet concentrates through screen or depth type microfilters did not cause significant numerical, biochemical or in vitro functional changes.
Complement activation
Paradoxically, MA formation by microfilters following complement system activation has been reported 42 . Yellon and colleagues 44 demonstrated a 17% increase in C3 when nylon filter material was incubated with heparinized blood for 60 minutes. Complement activation was less when citrated blood was passed through microfilters 45 with only a 3% rise in C3 levels. This is probably because citrate chelates Mg 2+ and Ca 2+ ions, which are essential for coagulation and complement activation. This postulate was confirmed by Synder 45 in both experimental and clinical settings. A difference in extent of complement activation might also depend on the material used in the microfilter 46 . However animal 47 and human 45 studies show that even though MAs secondary to complement activation by microfilters are present, they are too small to be detected histologically in the lung or to produce a clinical risk, and thus the phenomenon is not of great significance.
Absorption of Proteins
Walsh et al 48 observed that cellulose-nitrate-containing filters remove IgG and to a lesser extent IgA and IgM, but there was no significant adsorption of albumin or transferrin by any of the filters studied. If the filters were pre-washed with polyethylene glycol, IgG adsorption was not seen.
Release of foreign particles
Because of the inability to flush individual filters during manufacture, there is a theoretical possibility of foreign particles being released into the blood when using depth filters 3 .
Recommendations for Usage of Microfilters
We conclude that there are no guidelines supporting the routine use of microfilters during blood transfusion and use is not justified. Microfilters meet the specifications of American Association of Blood Banks (AABB) for reducing leucocytes to the desired number per unit of blood to prevent NHFTRs 7 . Despite successfully producing leucocyte-depleted blood and preventing febrile reactions, they fail to comply with AABB standards for prevention of transmission of CMV or HLA alloimmunization and should not be used for these purposes. The third edition of the booklet Questions and Answers About Transfusion Practices, by the 1996-97 Committee on Transfusion Medicine of ASA (American Society of Anesthesiologists) 49 does not recommend the routine usage of microfilters, even when large volumes of blood are administered. The only indication cited is cardiopulmonary bypass (arterial inflow cannulae), during which MAs can enter the systemic circulation.
THIRD GENERATION BLOOD FILTERS (LEUCOCYTE REDUCTION FILTERS)
Leucocyte reduction refers to decreasing the number of residual donor leucocytes in cellular blood components such as packed red blood cells and platelets. The current guidelines of the AABB and the United States Food and Drug Administration (FDA) for leucocyte reduction are as follows: Leucoreduced whole blood, leucoreduced packed red blood cells and leucoreduced apheresis platelets should contain no more than 5x10 6 leucocytes per unit. Leucoreduced platelet concentrates should contain 421 FILTERS IN ANAESTHESIA AND INTENSIVE CARE no more than 0.83x10 6 leucocytes per unit. By comparison, European standards demand a count of less than 1x10 6 leucocytes per unit 50 . However there is no scientific evidence favouring either of the values. Nevertheless, when used properly, current filters are capable of producing components with residual leucocyte counts well below 10 6 .
Of the various techniques available for leucocyte reduction, filtration is the most frequently used because it is simple, rapid and cost-effective. While early leucocyte filters were capable of achieving only 90-99% (1-2 log 10) leucocyte reduction, current high performance leucocyte removal filters reduce residual white blood cell content by at least 3 logs ( Table 1) .
Uses of Leucoreduction Filters
Leucoreduction of blood and blood products aims to reduce certain complications associated with transfusion of a residual leucocyte population.
Non-haemolytic Febrile Transfusion Reactions (NHFTRs)
The use of leucoreduced packed red blood cells performed before or after storage is extremely effective in preventing these reactions 20, 51, 52 . However in the case of platelet units that have been leucoreduced after storage, pyrogenic cytokines may continue to accumulate and be released 53 , resulting in NHFTRs 54, 55 . Pre-storage leucoreduction of platelets may prove beneficial in preventing this cytokine accumulation 51, 52 .
Primary HLA Alloimmunization
HLA molecules on co-transfused leucocytes may cause HLA alloimmunization, leading to platelet refractory states and difficulty with solid organ and bone marrow transplant acceptance and maintenance. It is generally accepted that residual leucocyte counts of less than 5x10 6 leucocytes per unit will prevent HLA alloimmunization [56] [57] [58] and thus leucoreduction of allogenic blood decreases the incidence of HLA alloimmunization among patients with haematologic malignancy 52, 59 . A national trial designed to reduce alloimmunization to platelets (TRAP) also concluded that the incidence of HLA alloantibody sensitization was significantly lower among patients receiving leucoreduced platelets 60 . The beneficial effect on platelet refractoriness is said to be less pronounced when using leucoreduced products 52, 61 .
Hiruma et al 62 found that even fresh frozen plasma contains a leucocyte population in the range of 0.99-8.38x10 6 per unit and leucoreduction filters appear effective in suppressing its alloimmunogenecity.
Effect on Transfusion-Related Immunomodulation (TRIM)
A reduction in transfusion-related immunomodulation (TRIM) might be anticipated to reduce the incidence of postoperative infections and rate of recurrence of tumours after primary surgical resections. It is controversial whether leucoreduced products reduce the incidence of of TRIM 63 , with some studies after colorectal cancer, gastrointestinal and cardiac surgery showing a reduction and others not [63] [64] [65] [66] . There is clinical evidence both supporting and discrediting an association between leucocyte reduction and postoperative infections [66] [67] [68] [69] .
Cytomegalovirus (CMV) Transmission in At-Risk Recipients
A subset of patients is considered to be at high risk of clinical morbidity from transfusion transmitted cytomegalovirus (CMV) infection. This includes those with congenital immunodeficiency states, human immunodeficiency virus infection, CMV negative individuals, very low birth weight infants, bone marrow transplant patients, patients awaiting transplant surgery and those requiring long-term blood product support. In such patients the risk of transfusion transmitted CMV can be reduced by using CMV negative blood products or leucoreduced blood from CMV-positive or CMV-negative blood 61, [70] [71] [72] [73] .
Leucoreduction and SIRS (Systemic Inflammatory Response Syndrome)
In a recent study by Brown and associates 74 , the use of leucoreduced blood in SIRS was evaluated. Using a laboratory-designed extracorporeal circuit, leucoreduction of SIRS blood was seen to limit the binding of polymorphonuclear cells to blood vessel walls and thereby reduce pathological manifestations associated with SIRS.
Leucocyte reduction and its role in posttransfusion bacterial sepsis, especially related to Yersinia enterocolitica, is also a subject of on-going research [75] [76] [77] [78] [79] [80] [81] .
Complications of leucocyte reduction filters
Hypotension has been reported when leucocyte reduction filters are used for bedside filtration, especially among patients receiving ACE inhibitors [82] [83] [84] . Following several such reports an FDA Alert was issued in 1999. This suggested the aetiology was dysmetabolism of bradykinin, a potent vaso-dilator. Recommendations in the event of hypotension occurring were to watch for a precipitous fall in blood pressure; to immediately stop the transfusion and when indicated, to use blood products that were leucocyte-reduced at the time of collection or during laboratory storage.
Leucoreduction filters may cause a loss of certain coagulation factors and alter complement levels, dependant on the type and charge of filter used 85 . However, changes observed are unlikely to be clinically significant unless subsequent processing of plasma (such as pathogen inactivation) results in further coagulation factor loss.
Anaphylaxis attributed to a negatively charged leucodepletion filter has been reported 86 after initiating platelet transfusion through the filter in a patient with myelodysplastic syndrome.
Recommendations for use of Leucocyte Reduction Filters
The ASA document 49 , AABB recommendations 61 , and British recommendations 52 regarding the use of leucoreduction support use only for specific indications. Some situations in which leucoreduction has been used remain controversial or the benefit unproven, for example platelet refractoriness and immunomodulation.
The role of these third generation filters needs to be discussed and a consensus reached. In certain countries of Western Europe and Canada all blood components are now leucoreduced, whereas in the United States, Australia and Asia leucoreduction is indicated only under specific circumstances.
IN-LINE FILTERS
Administration of intravenous fluids or drugs allows microbiological as well as particulate contamination of blood stream. The former includes both the presence of bacteria and biological by-products. While particulate contaminants may be a cause of post infusion phlebitis, the eventual sequelae of infused contaminants are dependent on their size. Particles larger than 8 µm are filtered by the lung and may result in pulmonary granulomas, particles smaller than 8 µm are cleared by phagocytosis and ultimately presented to liver and spleen.
Contamination of Intravenous Infusates and Equipment
Trautmann and colleagues 87 studied bacterial colonization and endotoxin contamination of intravenous infusion fluids and catheter systems in an intensive care unit. The rate of bacterial colonization of bottles/burettes was 7.8% at 48 hours after commencing infusions and rose to a significantly higher incidence of 15.7% at 96 hours. At both these time intervals studied, the colonization rates of catheter fluid were higher than that in bottles/burettes (34% and 24.1% respectively). Cell-bound endotoxin was found in 8.8% of samples, even though only 2.5% of the samples contained free endotoxin.
Uses of In-line Filters Septicaemia
Whether prevention of bacterial and endotoxin influx into patients from the contaminated fluid and fluid systems results in decreased incidence of septicaemia remains to be proven. Our search identified a single study looking into this aspect, which was the experience in an Australian paediatric teaching hospital 88 . In this prospective study a total of 19,221 intravenous days were monitored spread over oneyear periods before and after withdrawal of in-line intravenous filters from central venous access in 88 children. There were no differences in incidence of septicaemia between children with filters fitted and those without.
Phlebitis and Intravenous Line Survival
Incidence of phlebitis and intravenous line survival of peripheral intravenous catheters in patients receiving drugs through in-line filters was found to be the same as in those without an in-line filter but receiving infusates containing heparin 500 units and hydrocortisone 10 mg/l 89 . The authors concluded that use of filters, while decreasing incidence of phlebitis and increasing survival time of peripheral intravenous cannulae also served to circumvent heparin/hydrocortisone-related problems. Falchuk and colleagues 90 studied the effect of a filter on the incidence of phlebitis associated with intravenous infusion in 541 patients in a double-blinded prospective study. The incidence was reduced by approximately two thirds in patients infused through a 0.22 µ IVEX-HP filter. On the contrary, the same year Hessov 91 noted that the efficacy of in-line membrane filters to prevent infusion phlebitis is not convincing, Richards et al 92 reported no significant improvement associated with the use of filters to prolong the life of intravenous cannulae in patients with cystic fibrosis receiving intravenous antibiotics.
Other Uses
By prolonging the intravenous life of central cannulae the decrease in expenditure incurred in an ICU has been calculated to be a substantial amount of up to £stg35,000 per year 93 .
Use of in-line filters to aspirate drugs from ampoules has been noted to decrease glass particle contamination 94 . The average number of glass particles aspirated per ampoule was noted to be 1.2±0.3 if an in-line filter was used and 100.6±16.3 without.
Complications with In-line Filters
Absorption of drugs delivered through in-line filters has been studied by several authors. Studies negating as well as confirming the problem could be found. Hirakawa and colleagues 95 found that in-line filters decrease concentration of amphotericin B in filtered fluid, the proportion being dependent on the type of filter material used. Other authors have also reported a decrease in the availability of drugs such as digoxin and diazepam when infused through in-line filters 96 .
Contrasting with the above results, Stevens and Wilkins 97 found 96% or greater recovery of four cytotoxic drugs, namely mitozantrone, doxorubicin, daunorubicin and methotrexate through an 0.2 µm endotoxin retentive end-line filter. Similarly, other authors have reported lack of significant binding of vancomycin 98 , phenobarbitone 98 , isosorbide-5mononitrate 99 and fentanyl 96 to in-line filters.
Other complications associated with the use of in-line filters include air locking and clogging 100 .
Recommendations For Usage of In-line Filters
Notwithstanding the rather limited and controversial data and opinions voiced regarding use of inline filters 101 (Figure 2 ), their use is recommended with parenteral nutrition infusions 102, 103 . This is in keeping with a recent FDA (USA) Safety Alert recommendation for in-line filtration of all total parenteral nutrition admixtures.
The use of these filters for fluid and drug infusions lacks a large database and our search failed to reveal any guidelines or recommendations for their use. It is to be reiterated that large scientific trials have yet to confirm the utility of this practice.
BREATHING SYSTEM FILTERS (BSFs)
The controversy regarding usage of bacterial and viral filters in breathing systems is fuelled by the increasing awareness of infection risk during anaesthesia. Infections can be transmitted through breathing systems either by gaseous dispersion or in blood and secretions. Blood is present quite commonly in the airway of intubated patients 104, 105 , but the incidence of blood in the mouth of non-intubated patients is much lower-1% versus 76% 106 . Thus anaesthetic apparatus may be a source of cross infection of bloodborne infection. Traditionally, the same breathing circuit was commonly used for several consecutive patients.
The risk, if any, of a contaminated breathing system leading to crossinfection of patients is considered before discussion of the role of BSFs in decreasing morbidity. Evidence has been gathered from previous reviews on the topic 1,2 , cross referencing and a Medline ® search of all English language text and abstracts for the years 1995-2001.
Contamination of breathing systems
Breathing systems can be contaminated by microorganisms originating from the patient as well as the environment. Lutttropp and Berntmann 107 found that seven of eight contaminated unused sets of breathing system tubing grew bacteria such as Staphylococcus epidermis, Propionibacterium acnes and Micrococcus. Both Shiotani et al 108 and du Moulin and Saubermann 109 demonstrated that the contamination of clean unused breathing system tubing was by microbes of environmental origin. These microbes were of low pathogenicity and have not been implicated in the aetiology of postoperative infection. No text was found implicating contamination of breathing systems by microbes of high pathogenicity.
Several authors have studied breathing system contamination experimentally by simulation, using nebulized bacterial aerosol. After spraying bacterial aerosol into the anaesthetic and ventilator breathing system, tubing is variably contaminated (12% 110 to 71% 108 ) with nebulized bacteria. Up to one metre of corrugated tubing can be traversed by 50% of airborne salivary organisms 111 . Langevin et al 112 reported that, if the gas flow through a circuit was interrupted for up to an hour following the nebulization period, almost 100% of the organisms could be collected from the inspiratory gas.
There are also several relevant clinical studies regarding direct contamination. Pandit et al 113 examined anaesthetic equipment that had been exposed to patients with several different infections, including tonsillitis, pharyngitis, lung abscess, bronchiectasis and pulmonary tuberculosis, and confirmed contamination had occurred. Importantly, they concluded that most organisms isolated from the equipment were commensals or low pathogenic organisms such as Staphylococcus albus, Streptococcus viridians and diptheroids. Pathogenic organisms like Pseudomonas aeruginosa and Staphylococcus pyogenes were principally isolated from the facemask and angle piece. Retrograde contamination of the inspiratory tubing against gas flow has also been demonstrated 114 .
This colonization of a breathing system may be rapid. Craven et al 115 found 33% of the sets of tubing studied were colonized within two hours and 80% in 24 hours. The colonization of humidification apparatus, which may also be a source of bacteria, was equally rapid. Malecka-Griggs and Reinhardt 116 were the first to perform a qualitative and quantitative microbial assessment of breathing system using direct dilution sampling. Within 24 hours 95% of ventilator breathing systems, 57% of water traps, 55% of cascade humidifiers and 85% of inspiratory tubing became contaminated, the microbes being predominantly gram-negative non-fermenters. Other authors 117-120 also support contamination of breathing systems by bacteria from patients.
There are several studies that fail to confirm contamination of anaesthesia equipment after patient use. Ibrahim and Perceval 121 suggested that patients do not contaminate breathing system tubing. Nielson and associates 117 showed that gas from a previously used anaesthetic system is contaminated only to the same extent as hospital air, and with bacteria of low pathogenicity. Stemmermann and Stern 122 failed to demonstrate contamination of an anaesthetic circuit by Mycobacterium tuberculosis after use in individuals with known active pulmonary tuberculosis. Ziegler and Jacoby 123 found that colonization did not occur despite use for up to four hours.
In conclusion, there is contradictory and inconsistent evidence regarding the potential for microbial contamination of breathing systems by patients. If contamination occurs it is usually by non-pathogenic organisms. Such organisms are probably only expelled from the airway during forceful expiration, such as by a cough or sneeze 124 . During quiet breathing under anaesthesia, very few organisms are liberated, even from an infected patient 125 .
Cross infection with Breathing Systems
There are several studies implicating contamination of anaesthetic equipment as a cause of respiratory infections and morbidity. Phillips and Spencer 126 reported an outbreak of pseudomonas infection in patients under mechanical ventilation that resulted in the death of two patients. They pointed to heavy contamination of ventilator parts with pseudomonas, particularly the humidifier and the inspiratory tubing. Another report 127 also emphasised the problem of ventilator contamination with pseudomonas in intensive therapy units and ventilatory equipment associated outbreaks of pulmonary infection are extensively documented [128] [129] [130] [131] [132] [133] [134] .
In contrast, some studies do not support crossinfection of patients secondary to anaesthetic equipment contamination. Pandit et al 113 examined gas passing through an artificially contaminated circuit attached to a Boyle's machine and found no organisms could be isolated, as did Ibrahim and Perceval 121 after seeding anaesthetic circuit tubing with Streptococcus viridans and Staphylococcal bacteriophage. du Moulin and Saubermann 109 deliberately contaminated the expiratory port of a breathing circuit and ventilated the circuit for three hours at fresh gas flow of 6 l/min. They reported the disappearance of inoculums over several hours. These and other studies support the view that evidence implicating the role of anaesthetic machines and breathing circuits in patient infection is weak 127, 135, 136 .
It should be noted that almost all studies implicating anaesthetic equipment as a vector for spread of infection between patients are narratives or retrospective reviews. There are no randomized controlled trials in this area and an obvious failure to mention other possible sources of infection or infection control measures taken to interrupt outbreaks of infection.
Role of Filters in Breathing Systems
Using filters in the breathing system ( Figure 3) and then re-using the breathing circuit is common practice [137] [138] [139] . The utility of breathing system filters lies in a potential decrease in the incidence of respiratory morbidity. There is evidence that the incidence of bacterial pneumonia is less when a BSF is used in ICU patients 130, 140, 141 . As expected, a marked decrease in recovery of bacteria from the anaesthesia breathing system when using filters has been well demonstrated 107, 108, 119, 130 .
Compared to this setting of prolonged ventilation in ICU, there are fewer studies evaluating the role of BSFs during anaesthesia. Pottecher et al 142 found a high contamination rate of the Y-piece, with or without a filter. However, the bacterial titre was extremely low. Nevertheless, many studies demonstrate the efficacy of BSFs 107, [143] [144] [145] . Most have a small sample size, but Vezina et al 145 studied breathing system contamination with a filter in place in 2,001 patients. In vivo filtration efficacy was 98.08%, indicating that the cross-contamination rate in the breathing system is less than 1 in 250 when a BSF is used.
Some authorities do not support the use of filters in breathing circuits because of failure to reduce the incidence of ventilator-associated pneumonia 146 or respiratory infection. A surveillance of postoperative respiratory tract infections carried out over nine years 147 concluded that patient factors are most important in the development of postoperative lower respiratory infections and that the value of a bacterial filter as a preventive measure is negligible.
Complications of Breathing System Filters
BSFs may adversely affect end-tidal carbon dioxide measurement 148 . Hypocapnia on the machine side of the system, probably caused by the extra deadspace and increased resistance of the filter, has been documented 148 . The resistance to gas flow increases significantly during anaesthesia because of condensation on the filter 149 . Loss of capnograph tracing and of ventilatory volume monitoring, due to mixing of gas at low tidal volume, has been reported 149 . BSFs have been incriminated as a cause of barotrauma, pneumothorax 150, 151 and obstruction 152 . Bronchospasm has followed the use of a filter inappropriately sterilized with formaldehyde, the inhalation of which resulted in diffuse bronchospasm 153 .
Types of Breathing System Filters
These filters can be broadly divided into two groups: a) Pleated, hydrophobic membrane filters: These have a large surface area and very small pores, such that the membrane area has to be large to minimize airflow resistance. To maintain a small filter size the large membrane is folded (pleated). The design prevents ingress of water droplets, ensuring that liquids do not pass through and that airflow resistance remains low even under wet conditions. b) Composite filters: They consist of a hygroscopic layer and a large pore felt filter layer. The felt is sometimes subjected to an electric field, an electret felt, to increase its polarity (electrostatic filters). This process improves dry gas filtration efficiency while maintaining a low airflow resistance. In comparison to hydrophobic pleated filters, electrostatic filters are unable to prevent the passage of water 154 . This property is a consequence of the smaller internal volume, a larger volume of water added, and a horizontal rather than vertical filter layer in composite filters 154 . Several authors have compared the performance of these two types of BSFs, and most concluded that electrostatic filters are less efficient than pleated hydrophobic filters [155] [156] [157] [158] [159] [160] [161] .
Methods of Testing Performance
All BSFs are assessed for bacterial filtration efficiency and less often for viral filtration efficiency using various methods [155] [156] [157] [158] [159] [160] [161] . Viral filtration efficiency is more difficult to assess, as the viral suspension required to challenge the filters requires initial preparation in a bacterial medium. The suspension is then cleared and collected over a suitable surface, such as an agar plate overlayed with bacteria, that supports viral growth.
The wide array of test methods for studying efficiency of filters is an independent reason why results comparing different filters are variable. Recently, a standard for respiratory protective devices has been published by the National Institute for Occupational Safety and Health 162 using sodium chloride crystals as challenge particles. Based on these standards, a draft European standard for BSFs has now been proposed 163 . This will hopefully meet the long felt need for a standard and uniform test of BSFs and enable objective comparisons to be made.
Recommendations for use of Breathing System Filters
Recommendations of the (American Society of Anesthesiologists 164 , Centres for Disease Control 165 and the Canadian Laboratory Centre for Disease Control 166 do not endorse the use of BSFs. The American Society document notes "there is insufficient clinical outcome data to support the routine use of bacterial filters for breathing circuits or anesthesia ventilators at this time" 164 . However it does recommend using a filter on the anesthesia breathing circuit between the patient's airway and the Y-connector, prior to contacting a patient with, or at high risk of, pulmonary tuberculosis. The Canadian Laboratory Centre for Disease Control "requires, at a minimum, high-level disinfection" of breathing circuits between use but makes no mention of the use of BSFs 166 .
The only organization to advocate BSFs is the Association of Anaesthetists of Great Britain and Ireland 167 . Their working group considering bloodborne virus infection had investigated the report from a private hospital in Australia, where the anaesthetic breathing system was implicated in transmission of Hepatitis C virus between patients 168 . In response to this investigation they made the following recommendations: a) Either an appropriate filter should be placed between the patients and the breathing system, with a new filter used for each patient, or a new breathing system used for each new patient. b) Where expired gas sampling is used the sample should be taken from the breathing system side of the filter. c) In paediatric practice where use of filter would increase deadspace and/or resistance unacceptably, filters should not be used but the breathing system should be changed between patients. An innocuous argument offered in the favour of BSF use is the reduction in cost incurred, without patient harm, despite no proven decrease in the rate of cross-infection. If the cost of a filter is significantly less than that of a breathing circuit or its sterilization, a cost-benefit may be achieved.
Regarding the more pertinent and controversial issue regarding prevention of cross-infection, much remains to be answered. With respect to the incident of Hepatitis C transmission reported by Chant et al 168 , that led to the recommendation of the Association of Anaesthetists of Great Britain and Ireland 167 in favour of using filters, it must be appreciated that there could have been several alternative explanations. The most obvious of these were excluded and the breathing system incriminated only by a process of exclusion.
We consider there are several reasons that make an attempt to justify routine usage of filters in breathing systems presumptive and non-scientific. First there is a definite lack of prospective randomized controlled trials. Second, the outcome measure of most relevance is postoperative respiratory morbidity and mortality, rather than the widely investigated microbial contamination of breathing systems. Respiratory morbidity is a difficult outcome to evaluate, given its low incidence in the general surgical population and multitude of causes. Third, BSFs need to be effective against airborne, as well as liquid-borne, contamination and the spectrum of efficacy should include bacteria, viruses, fungi and mycobacterium. Mostly filters are tested only for bacterial efficacy, with adequate viral filtration efficacy reported in very few studies. Fourth, these shortcomings are compounded by the lack of a standard method of testing filters. Last, whenever studies are performed or cases incriminating the breathing system as the vector for cross-infection are reported, alternative routes of cross-infection are rarely mentioned.
In conclusion, the use of microbial filters in longterm ventilated patients in ICU appears an appropriate option, given evidence showing a reduction of condensation and bacterial colonization in circuits, and of respiratory tract infections. The same cannot be concluded in the shorter setting of anaesthesia, where there are far fewer studies and evidence for a benefit is lacking. Thus, even though BSFs have become an accepted method of infection control, the scientific evidence does not support routine use. In addition, BSFs are only one of several methods of cross-infection control, given multiple possible sources of contamination, and the presence of a filter does not make sterilization of the connectors and the ventilator circuits unnecessary.
EPIDURAL FILTERS
The last decade has witnessed an increasing role for analgesia via long-term epidural catheterization. Microbial colonization of epidural space is a serious complication because of the possible delayed appearance of symptoms of infection and the poor prog-427 FILTERS IN ANAESTHESIA AND INTENSIVE CARE nosis. Prospective studies reveal the prevalence of positive bacterial culture to be as high as 22% following routine testing of epidural catheters 169, 170 . Du Pen et al 171 reported an epidural infection rate of 5.4% in immunocompromised patients receiving prolonged epidural analgesia.
There can be three routes of contamination of an epidural catheter: 1) from the skin via the needle track (entry point), 2) haematogenous spread, and 3) through the catheter. The catheter hub has been recognised as the main route of microbial colonization 170, 171 . Thus it appears logical to use a microbial filter on an epidural catheter ( Figure 4 ) to prevent infection in the epidural space.
A literature search provided little information about epidural catheter filter use. Discussing the results of a double-blind prospective study Abouleish et al 172 suggested that bacterial filters were not required if sound sterile techniques were applied. The reasons cited were the effectiveness of precautions for each refill injection, the antimicrobial activity of local anaesthetics, the small number of injections and the limited duration of catheter insertion 173, 174 . In contrast, use of a filter was recommended by James et al 173 after their study in 101 labouring patients, which was not however a randomized trial. Several other authors have reported on the traditional use of epidural catheter filters during pain relief in cancer patients [175] [176] [177] .
These filters may prevent foreign particulate matter, such as glass particles, from gaining access to the epidural space.
Recommendations for Epidural Catheter Filters
Given the lack of data, it cannot be assumed these filters are useful, especially during short-term catheterization. They may also not be foolproof with respect to filtration of foreign particulate matter. Friable or shreddable foreign material can be caught in the epidural needle and projected into the epidural space as the catheter is advanced 178 . A filter needle may be a cheaper, adequate and less cumbersome means of aspirating drugs from glass ampoules and protecting the epidural space from inoculation with foreign material 179 .
We were unable to locate any specific guidelines regarding epidural filters in short or long-term usage. Given the relative lack of pertinent prospective trials, even with long-term epidural catheterization, practice appears to be influenced more by logical reasoning than sound scientific evidence. Use of a filter is common [175] [176] [177] , and apparently without detriment to the patient. The cost is not high, given the conclusions of several authors [175] [176] [177] 180 that filters need not be changed for at least a month. Thus, pending prospective randomized controlled trials, long-term epidural catheterization may merit use of a bacterial filter.
FILTERS IN CONVECTION WARMERS
Forced air convection warming devices used for the management of hypothermia have a microbial filter (0.2 µm pore size) that manufacturers recommend should be changed every six months or after 600 hours of use. A single study 181 found that these warmers, when used in the operating theatre, were potential sources of microbial infection due to colonization of their hoses. Since a filter cannot prevent colonization distal to it, the authors recommend fixing the microbial filter to the nozzle of the hose connecting the warmer to heating blanket.
FILTERS IN ENTONOX EQUIPMENT
Filter use has also been recommended on Entonox equipment 182, 183 . However it should be emphasized that these reports were surveys and not controlled trials. There is no evidence indicating cross-infection of unintubated patients associated with Entonox apparatus, or to support the efficacy of BSFs to prevent such a risk, should it exist.
FILTERS IN AIR CLEANING
The use of filters in air-conditioning systems is ubiquitous and there are no controversies. Most com- mercially available filters remove almost all bacteria and a few special filters also remove inorganic particles sized 0.1 µm. In operating rooms and intensive care units, ideally two filter beds are indicated. The first should be upstream of the air-conditioning equipment and have a filtration efficiency of 25%. The second filter bed should be downstream of the supply fan, any recirculating spray water systems, and the water-reservoir type humidifier, and have filtration efficiency of 90% to 95%.
SUMMARY
This review focuses on a number of commonly used filters in anaesthesia and intensive care. The practicalities of use and opinions regarding their value in clinical practice are as varied as their sites of usage. First generation blood filters, filters used during total parenteral nutrition and filters for air-conditioning are the only types free from controversy and recommended for routine usage. The other filters, including microfilters, leucocyte depletion filters, breathing system filters, epidural catheter filters, in-line filters for fluid and drug administration and filters for Entonox delivery in unintubated patients, cannot be recommended for routine use.
